A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

NCT06873945 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Treatment of Alopecic Scars by Follicular Unit Extraction Hair Transplantation

NCT06145672 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

NCT07029828 ·Status: RECRUITING ·Phase: PHASE3

A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age

NCT05650333 ·Status: COMPLETED ·Phase: PHASE1

1565nm Non-ablative Fractional Laser Treat Alopecia Areata

NCT05744505 ·Status: UNKNOWN ·Phase: NA

A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings

NCT07200128 ·Status: COMPLETED

Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia

NCT02014584 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata

NCT06157905 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata

NCT07174011 ·Status: COMPLETED ·Phase: PHASE4

A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia

NCT00441116 ·Status: COMPLETED ·Phase: PHASE3

Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth

NCT02793557 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Alefacept in Patients With Severe Scalp Alopecia Areata

NCT00167102 ·Status: COMPLETED ·Phase: NA

Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata

NCT03800979 ·Status: COMPLETED ·Phase: PHASE4

Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

NCT06531109 ·Status: RECRUITING

A Study of KL130008 in Adults With Severe Alopecia Areata

NCT05496426 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.

NCT07205159 ·Status: RECRUITING ·Phase: PHASE1

A Study of LAD603 in Adults With Alopecia Areata

NCT07311564 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study

NCT05129800 ·Status: COMPLETED

Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study

NCT06202560 ·Status: COMPLETED ·Phase: NA

A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers

NCT04774874 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia

NCT05611593 ·Status: RECRUITING ·Phase: PHASE1

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

NCT04556734 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

NCT07133308 ·Status: RECRUITING ·Phase: PHASE3

Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia

NCT04409041 ·Status: COMPLETED ·Phase: PHASE2

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

NCT05522556 ·Status: AVAILABLE